Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Fitoterapia|February 7, 2016
Modulation of WNT/β-catenin pathway in melanoma by biologically active components derived from plantsAnna Gajos-Michniewicz, Malgorzata CzyzInternational Journal of Molecular Sciences|July 15, 2020
WNT Signaling in MelanomaAnna Gajos-Michniewicz, Malgorzata CzyzInternational Journal of Molecular Sciences|December 17, 2024
Therapeutic Potential of Natural Compounds to Modulate WNT/β-Catenin Signaling in Cancer: Current State of Art and ChallengesAnna Gajos-Michniewicz, Malgorzata CzyzGenes & Diseases|September 11, 2023
WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunitiesAnna Gajos-Michniewicz, Malgorzata CzyzCancer Letters|February 12, 2014
MiRNA in melanoma-derived exosomesAnna Gajos-Michniewicz, Markus Duechler, Malgorzata CzyzCells|November 13, 2025
Cellular and Molecular Effects of Targeting the CBP/β-Catenin Interaction with PRI-724 in Melanoma Cells, Drug-Naïve and Resistant to Inhibitors of BRAF<sup>V600</sup> and MEK1/2Anna Gajos-Michniewicz, Michal Wozniak, Katarzyna Anna Kluszczynska, et al.Plos One|June 3, 2015
MCL-1, BCL-XL and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in MicroenvironmentMariusz L Hartman, Beata Talar, Anna Gajos-Michniewicz, et al.Journal of Bone and Mineral Metabolism|February 8, 2012
The influence of follistatin on mechanical properties of bone tissue in growing mice with overexpression of follistatinAnna Gajos-Michniewicz, Elzbieta Pawlowska, Tomasz Ochedalski, et al.Cells|January 16, 2020
Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic PlasticityMariusz L Hartman, Malgorzata Sztiller-Sikorska, Anna Gajos-Michniewicz, et al.Pageof 2